metricas
covid
Revista Argentina de Microbiología / Argentinean Journal of Microbiology Ahead of print
Journal Information

Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Estimación de las dosis estandarizadas de las formulaciones intramamarias para uso en bovinos disponibles en Argentina
Agostina Peña, Cecilia Camussone, Facundo Tello, Camila Miotti, Joaquín Cicotello, María Virginia Zbrun, Marcelo Signorini, Ana Inés Molineri
10.1016/j.ram.2025.10.004
Highlights

  • El uso indebido de AM en animales favorece la aparición de bacterias resistentes.

  • Treinta laboratorios expenden pomos intramamarios para tratamiento de mastitis clínicas.

  • Ampicilina y cloxacilina fue la combinación más frecuente en pomos intramamarios.

  • La formulación más común, en el caso de los pomos de secado fue la cloxacilina.

  • Tres productos contenían al menos un AM de importancia crítica de máxima prioridad.

Full text access
Available online 18 November 2025
Fungal degradation of PLA/PBAT bioplastics and plastic polymers by Aspergillus sp.
María Victoria Valerga Fernández, Sofía Yasmín Utge Perri, Roxana Paula Colombo, Laura Moyano, Alicia Margarita Godeas, Vanesa Analía Silvani
10.1016/j.ram.2025.10.003
Full text access
Available online 18 November 2025
Microorganisms involved in the fermentation process of specialty coffees in Southwestern Colombia identified as potential starter cultures
Erick Fernando Collazos-Chaves, Arsenio Hidalgo-Troya, Nelson Humberto Hurtado-Gutiérrez, Dolly Margot Revelo-Romo
10.1016/j.ram.2025.09.009
Highlights

  • Microbial strains with functional properties for starter culture candidates.

  • Collection of microorganisms from Colombian coffee fermentation has potential uses.

  • Strains of microorganisms with high PME and PL enzymatic activity were identified.

  • Co-culture of Leuconostoc and Pichia strains with the potential to ferment coffee.

Full text access
Available online 14 November 2025
Hepatitis A in Central Argentina: Anti-HAV prevalence in adults living in a region of low endemicity 17 years after the official introduction of the vaccine
Gonzalo M. Castro, Vanesa Mamani, Jorge Mariojouls Bringas, Pablo Chumacero, Paola Díaz, Graciela Scruzzi, Maribel Martínez Wassaf, Mariel A. Borda, ... Viviana E. Ré
10.1016/j.ram.2025.08.002
Highlights

  • In Argentina, about 55% of unvaccinated adults <35 years are susceptible to HAV.

  • HIV status was not associated with the presence of anti-HAV antibodies.

  • Targeting vaccination at susceptible adults is needed to reduce the HAV incidence.

  • HAV immunity studies are useful to redefine prevention policies.

Full text access
Available online 17 October 2025
Antimicrobial susceptibility of Clostridioides difficile. An Argentinian multicenter study of isolates from human patients
Raquel Rollet, Daniela Vaustat, Mirta Litterio, Liliana Castello, Liliana Fernández-Canigia, Claudia Barberis, María Cristina Legaria, Natalia Azula, ... María Adelaida Rossetti
10.1016/j.ram.2025.09.006
Highlights

  • Vancomycin and metronidazole are the most active agents in vitro against C. difficile.

  • Differences in clindamycin, imipenem, moxifloxacin, rifaximin resistance among centres.

  • Rifaximin, moxifloxacin resistant C. difficile related to prevalence of tuberculosis.

  • First multicenter surveillance on in vitro susceptibility of C. difficile in Argentina.

Full text access
Available online 14 October 2025
Rift Valley Fever Virus: An update on current status and future prospects
Arwa Ahmed Zehairy, Sayed Sartaj Sohrab, Awatif Abid Al-Judaibi, Esam Ibraheem Azhar
10.1016/j.ram.2025.09.002
Highlights

  • RVFV is a mosquito-borne disease.

  • WHO has included this virus in Bluepoint list of 8 pathogens.

  • In KSA not much information is available.

  • This review discusses the status, pathogenesis, prevalence, challenges and future prospects of RVFV in KSA.

  • No vaccine is available for human use.

Full text access
Available online 14 October 2025
Trichoderma harzianum for the control of agricultural pests: Potential, progress, applications and future prospects
Hu Ding, Xinyang Li, Shumin Wang, Yang Yang, Xue Chen, Changbao Chen, Huan Wang
10.1016/j.ram.2025.09.004
Highlights

  • Trichoderma harzianum controls pests via multiple mechanisms.

  • Effective against a broad spectrum of pests via direct and indirect actions.

  • Application methods and synergistic combinations boost biocontrol efficacy.

  • Formulation and genetic advances enhance stability for sustainable agriculture.

Full text access
Available online 13 October 2025
Molecular identification of bacteria isolated from Tilapia (Oreochromis spp.) from the State of Hidalgo, Mexico. A potential source of foodborne diseases
Karen A. Terrazas-Pineda, Fabián-Ricardo Gómez-De-Anda, Liliana Alamilla-Beltrán, Nydia E. Reyes-Rodríguez, Víctor Johan Acosta-Pérez, Vicente Vega-Sánchez
10.1016/j.ram.2025.09.003
Highlights

  • Twelve bacterial genera were identified in Tilapia (Oreochromis spp).

  • Aeromonas, an opportunistic pathogen, was identified in Tilapia.

  • Shewanella, Vibrio, Pseudomonas, and others were found in Tilapia.

Full text access
Available online 13 October 2025
Microbial consortia as a biocontrol strategy for bacterial blight in basmati rice
Bestha Sai Teja, Vishal Gupta, Sushil Kumar Gupta, Ayushi Sharma, Zakir Amin, Fayaz Ahmad Mohiddin, Suhail Ashraf, Mona Saleh Al Tami, Khalid E. Hamed
10.1016/j.ram.2025.08.003
Highlights

  • Basmati rice is globally sought after for its fine, soft, long, aromatic grain.

  • The bacterial leaf blight disease significantly reduces yields in basmati rice.

  • Treating seeds with the consortium inhibited BLB incidence and improved growth.

  • Microbial treatments can be as effective as chemical controls for managing BLB.

Full text access
Available online 9 October 2025
Tuberculosis after solid organ transplantation: Clinical experience in a tertiary hospital from Argentina
Patricia Olga Andres, Elizabeth Madsen, Analía Laura Fernández
10.1016/j.ram.2025.09.001
Highlights

  • One third of the patients had extra-pulmonary or disseminated tuberculosis.

  • Invasive procedures were required to reach the diagnosis.

  • Treatment without rifampin showed good clinical outcomes.

Full text access
Available online 8 October 2025